
Juliet Caroline Switzer
Examiner (ID: 16746, Phone: (571)272-0753 , Office: P/1634 )
| Most Active Art Unit | 1634 |
| Art Unit(s) | 1634, 1655, 1682 |
| Total Applications | 1159 |
| Issued Applications | 375 |
| Pending Applications | 219 |
| Abandoned Applications | 588 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11979732
[patent_doc_number] => 20170283887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'DIAGNOSIS OF LUNG CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/529338
[patent_app_country] => US
[patent_app_date] => 2015-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16639
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15529338
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/529338 | DIAGNOSIS OF LUNG CANCER | Nov 23, 2015 | Abandoned |
Array
(
[id] => 16894313
[patent_doc_number] => 11035860
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => Auto-active and intracellular mutant of MET
[patent_app_type] => utility
[patent_app_number] => 15/528322
[patent_app_country] => US
[patent_app_date] => 2015-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 21
[patent_no_of_words] => 15230
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15528322
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/528322 | Auto-active and intracellular mutant of MET | Nov 17, 2015 | Issued |
Array
(
[id] => 10814119
[patent_doc_number] => 20160160279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-09
[patent_title] => 'PROGNOSIS OF RESPONSE TO TREATMENT WITH ANTI-TNF-ALPHA IN PATIENTS WITH RHEUMATOID ARTHRITIS'
[patent_app_type] => utility
[patent_app_number] => 14/930607
[patent_app_country] => US
[patent_app_date] => 2015-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6556
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14930607
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/930607 | PROGNOSIS OF RESPONSE TO TREATMENT WITH ANTI-TNF-ALPHA IN PATIENTS WITH RHEUMATOID ARTHRITIS | Nov 1, 2015 | Abandoned |
Array
(
[id] => 12227748
[patent_doc_number] => 09914982
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-13
[patent_title] => 'Compositions and methods for detecting hepatitis B virus'
[patent_app_type] => utility
[patent_app_number] => 14/827087
[patent_app_country] => US
[patent_app_date] => 2015-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 27954
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14827087
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/827087 | Compositions and methods for detecting hepatitis B virus | Aug 13, 2015 | Issued |
Array
(
[id] => 12206116
[patent_doc_number] => 20180051343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-22
[patent_title] => 'THYROID CANCER DIAGNOSIS BY DNA METHYLATION ANALYSIS'
[patent_app_type] => utility
[patent_app_number] => 15/502591
[patent_app_country] => US
[patent_app_date] => 2015-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 10928
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15502591
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/502591 | THYROID CANCER DIAGNOSIS BY DNA METHYLATION ANALYSIS | Aug 9, 2015 | Abandoned |
Array
(
[id] => 10422933
[patent_doc_number] => 20150307943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-29
[patent_title] => 'SINGLE NUCLEOTIDE POLYMORPHISMS ASSOCIATED WITH BULL FERTILITY'
[patent_app_type] => utility
[patent_app_number] => 14/754729
[patent_app_country] => US
[patent_app_date] => 2015-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10238
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14754729
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/754729 | Single nucleotide polymorphisms associated with bull fertility | Jun 29, 2015 | Issued |
Array
(
[id] => 11122377
[patent_doc_number] => 20160319351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-03
[patent_title] => 'GENETIC VARIANTS AS MARKERS FOR USE IN DIAGNOSIS, PROGNOSIS AND TREATMENT OF EOSINOPHILIA, ASTHMA AND MYOCARDIAL INFARCTION'
[patent_app_type] => utility
[patent_app_number] => 14/747929
[patent_app_country] => US
[patent_app_date] => 2015-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 52452
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14747929
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/747929 | GENETIC VARIANTS AS MARKERS FOR USE IN DIAGNOSIS, PROGNOSIS AND TREATMENT OF EOSINOPHILIA, ASTHMA AND MYOCARDIAL INFARCTION | Jun 22, 2015 | Abandoned |
Array
(
[id] => 11649613
[patent_doc_number] => 20170145515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-25
[patent_title] => 'MOLECULAR MAMMOGRAPHY'
[patent_app_type] => utility
[patent_app_number] => 15/316136
[patent_app_country] => US
[patent_app_date] => 2015-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15629
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15316136
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/316136 | MOLECULAR MAMMOGRAPHY | Jun 1, 2015 | Abandoned |
Array
(
[id] => 11922987
[patent_doc_number] => 09790558
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-17
[patent_title] => 'Method and probe set for detecting cancer'
[patent_app_type] => utility
[patent_app_number] => 14/727536
[patent_app_country] => US
[patent_app_date] => 2015-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7633
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 219
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14727536
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/727536 | Method and probe set for detecting cancer | May 31, 2015 | Issued |
Array
(
[id] => 10452374
[patent_doc_number] => 20150337389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-26
[patent_title] => 'Use Of Genetic Modifications In Human Gene CHK1 Which Codes For Checkpoint Kinase 1'
[patent_app_type] => utility
[patent_app_number] => 14/718755
[patent_app_country] => US
[patent_app_date] => 2015-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 9701
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14718755
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/718755 | Use Of Genetic Modifications In Human Gene CHK1 Which Codes For Checkpoint Kinase 1 | May 20, 2015 | Abandoned |
Array
(
[id] => 14519643
[patent_doc_number] => 10337069
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-02
[patent_title] => Method for diagnosing hepatic fibrosis
[patent_app_type] => utility
[patent_app_number] => 15/305598
[patent_app_country] => US
[patent_app_date] => 2015-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 6332
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15305598
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/305598 | Method for diagnosing hepatic fibrosis | Apr 22, 2015 | Issued |
Array
(
[id] => 11436458
[patent_doc_number] => 20170037479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-09
[patent_title] => 'MARKERS FOR OVARIAN CANCER AND THE USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/302661
[patent_app_country] => US
[patent_app_date] => 2015-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 57
[patent_figures_cnt] => 57
[patent_no_of_words] => 18144
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15302661
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/302661 | MARKERS FOR OVARIAN CANCER AND THE USES THEREOF | Apr 7, 2015 | Abandoned |
Array
(
[id] => 11822209
[patent_doc_number] => 20170211147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'METHOD OF PREDICTING REACTION TO SORAFENIB TREATMENT USING GENE POLYMORPHISM'
[patent_app_type] => utility
[patent_app_number] => 15/302872
[patent_app_country] => US
[patent_app_date] => 2015-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8822
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15302872
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/302872 | METHOD OF PREDICTING REACTION TO SORAFENIB TREATMENT USING GENE POLYMORPHISM | Mar 22, 2015 | Abandoned |
Array
(
[id] => 11514650
[patent_doc_number] => 20170081723
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-23
[patent_title] => 'Fusion Genes in Cancer'
[patent_app_type] => utility
[patent_app_number] => 15/122554
[patent_app_country] => US
[patent_app_date] => 2015-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 71
[patent_figures_cnt] => 71
[patent_no_of_words] => 20743
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15122554
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/122554 | Fusion Genes in Cancer | Mar 22, 2015 | Abandoned |
Array
(
[id] => 11568933
[patent_doc_number] => 20170107577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-20
[patent_title] => 'Determining Cancer Aggressiveness, Prognosis and Responsiveness to Treatment'
[patent_app_type] => utility
[patent_app_number] => 15/125515
[patent_app_country] => US
[patent_app_date] => 2015-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 80
[patent_figures_cnt] => 80
[patent_no_of_words] => 60362
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 38
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15125515
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/125515 | Determining Cancer Aggressiveness, Prognosis and Responsiveness to Treatment | Mar 10, 2015 | Abandoned |
Array
(
[id] => 10437506
[patent_doc_number] => 20150322518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-12
[patent_title] => 'BIOMARKERS FOR AUTISM SPECTRUM DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/630205
[patent_app_country] => US
[patent_app_date] => 2015-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 18985
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14630205
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/630205 | Biomarkers for autism spectrum disorders | Feb 23, 2015 | Issued |
Array
(
[id] => 10282091
[patent_doc_number] => 20150167089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'Gene Mutations for the Diagnosis of Arthrogryposis Multiplex Congenita and Congenital Peripheral Neuropathies Disease'
[patent_app_type] => utility
[patent_app_number] => 14/575518
[patent_app_country] => US
[patent_app_date] => 2014-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13740
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14575518
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/575518 | Gene Mutations for the Diagnosis of Arthrogryposis Multiplex Congenita and Congenital Peripheral Neuropathies Disease | Dec 17, 2014 | Abandoned |
Array
(
[id] => 10275229
[patent_doc_number] => 20150160225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-11
[patent_title] => 'Renal Cell Carcinoma Biomarkers and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/566431
[patent_app_country] => US
[patent_app_date] => 2014-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 40441
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14566431
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/566431 | Renal Cell Carcinoma Biomarkers and Uses Thereof | Dec 9, 2014 | Abandoned |
Array
(
[id] => 11092696
[patent_doc_number] => 20160289663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-06
[patent_title] => 'NOVEL CHIMERIC GENE ATF7IP-PDGFRB OF ACUTE LYMPHOBLASTIC LEUKEMIA'
[patent_app_type] => utility
[patent_app_number] => 15/037907
[patent_app_country] => US
[patent_app_date] => 2014-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 20026
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15037907
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/037907 | NOVEL CHIMERIC GENE ATF7IP-PDGFRB OF ACUTE LYMPHOBLASTIC LEUKEMIA | Nov 16, 2014 | Abandoned |
Array
(
[id] => 11025493
[patent_doc_number] => 20160222449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'MAJOR HISTOCOMPATABILITY COPLEX SINGLE NUCLEOTIDE POLYMORPHISMS'
[patent_app_type] => utility
[patent_app_number] => 15/029224
[patent_app_country] => US
[patent_app_date] => 2014-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12149
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15029224
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/029224 | Major histocompatability complex single nucleotide polymorphisms | Oct 14, 2014 | Issued |